Plasmapheresis in severe forms of myasthenia gravis

Artificial Organs

Volumn 22, Issue 2, 1998, Pages 129-134

  Morosetti, Massimo ^a,c   Meloni, Carlo ^b   Iani, Cesare ^a   Caramia, Maria ^a   Galderisi, Cristina ^a   Palombo, Giuditta ^a   Gallucci, Massimo Taccone ^a   Bernardi, Giorgio ^a   Casciani, Carlo Umberto ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Istituto Tipizzazione Tissutale L'Aquila   (Italy)

^c S EUGENIO HOSPITAL   (Italy)

Author keywords

Myasthenia gravis; Myasthenic crisis; Plasma exchange; Steroids and plasmapheresis; Steroids in myasthenia

Indexed keywords

LIPIDS; PATIENT REHABILITATION; PATIENT TREATMENT;

BODY WEIGHT; CLINICAL EFFICACY; COMBINATION TREATMENTS; COMBINED THERAPY; MYASTHENIA GRAVIS; MYASTHENIC CRISIS; PATIENT'S SUFFERING; PLASMA EXCHANGES; STEROID AND PLASMAPHERESIS; STEROID IN MYASTHENIUM;

DISEASES;

CHOLINERGIC RECEPTOR; PREDNISONE; PYRIDOSTIGMINE; RECEPTOR ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MYASTHENIA GRAVIS; ORAL DRUG ADMINISTRATION; PLASMAPHERESIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031934135     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.1998.05061.x     Document Type: Article

References (18)

1. Kurtzke JF, Kurland LT. The epidemiology of neurologic diseases. In: Joynt RJ, ed. Clinical neurology. Rev. Ed. Vol. 4, Philadelphia: J.B. Lippincott, 1992:80-8.
2. Grob D, Arsura EL, Brunner NG, Namha T. The course of myasthenia gravis and therapies affecting outcome. Ann NY Acad Sci 1987;505:472-99.
3. Osserman KE, ed. Myasthenia gravis. New York: Grune & Stratton 1958:80.
4. Sanders DB, Scoppetta C. The treatment of patients with myasthenia gravis. Neurol Clin North Am 1994;12(2):343-68.
5. Dau PC. Response to plasmapheresis and immunosuppressive drug therapy in 60 myasthenia gravis patients. Ann NY Aca Sci 1981;337:700-8.
6. Antozzi C, Gemma M, Regi B, Berta E. Confalonieri P, Peluchetti D, Mantegazza R, Baggi F, Marconi M, Fiacchino F, Cornelio F. A short plasma exchange protocol is effective in severe myasthenia gravis. J Neurol 1991;238:103-7.
7. Dau PC, Lindstrom JM, Cassel CK, Denys EH, Shev EE, Spitler LE. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. N Engl J Med 1977;24:1134-40.
8. Mantegazza R, Antozzi C, Peluchetti D, Sghirlanzoni A, Cornelio F. Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis. J Neurol 1988; 235:449-53.
9. Johns TR. Long term corticosteroid treatment of myasthenia gravis. Ann NY Acad Sci 1987;505:568-83.
10. Seybold ME, Drachman DB. Gradually increasing doses of prednisone in myasthenia gravis: Reducing the hazards of treatment. N Engl J Med 1974;290:81-4.
11. Pinching AJ, Peters DK, Newsom-Davis J. Remission of myasthenia gravis following plasma exchange. Lancet 1976;2: 1373-6.
12. Keesey J, Buffkin D, Kebo D, Ho W, Herrmann C Jr. Plasma exchange alone as therapy for myasthenia gravis. Ann NY Acad Sci 1981;377:729-43.
13. Nielsen VK, Paulson OB, Rosenkvist J, Holsoe E, Lefvert AK. Rapid improvement of myasthenia gravis after plasma exchange. Ann Neurol 1982;11:160-9.
14. Milner-Brown HS, Miller RG. Time course of improved neuromuscular function following plasma exchange alone and plasma exchange with predinisone/azathioprine in myasthenia gravis. J Neurol Sci 1982;57:357-68.
15. Newsom-Davis J, Wilson SG, Vincent A. Long term effects of repeated plasma exchange in myasthenia gravis. Lancet 1979; 1:464-8.
16. Drachman DB. Myasthenia gravis: Review article. N Engl J Med 1994;330(25):1797-1810.
17. Grob D, Simpson D, Mitsumoto H, Hoch B, Mokhtarian F, Bender A, Greenberg M, Koo A, Nakayama S. Treatment of myasthenia gravis by immunoadsorption of plasma. Neurology 1995;45:338-44.
18. Morosetti M, Meloni C, Taccone Gallucci M, Rossini PM, Felicioni R, Palombo G, Boccasena P, Casciani CU. Plasmapheresis versus plasmaperfusion in acute Guillain Barré syndrome. ASAIO J 1994;40(3):638-42.